Gland Pharma Share Price
Know More₹1,245.00 13.25 (1.08%)
00:00 AM, 22-Mar-2023BSE : 543245
NSE : GLAND
Sector : Health care
ISIN Code : INE068V01023
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: 22-Mar-2023
| Market Cap (₹ Cr) | 20,505 |
Traded Value (₹ Cr) | 4.16 |
Volume (Shares) | 33,447 |
Face Value (₹) | 1 |
52-Week High (₹) | 2,220.95 |
52-Week High Date | 06-Aug-2024 |
52-Week Low (₹) | 1,222.50 |
52-Week Low Date | 22-Mar-2023 |
All Time High (₹) | 4,350.00 |
All Time High Date | 12-Aug-2021 |
All Time Low (₹) | 861.50 |
All Time Low Date | 22-May-2023 |
Gland Pharma Ltd
Gland Pharma News
Gland Pharma Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Data Not Found | |
Funds Owning this Stock
| Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
|---|---|---|---|
| Aditya Birla SL Equity Hybrid '95 Fund (IDCW) | 47.35 | 3,25,509 | 0.64 |
| Aditya Birla SL Equity Hybrid '95 Fund-Direct (G) | 47.35 | 3,25,509 | 0.64 |
| Aditya Birla SL Equity Hybrid '95 Fund-Direct (IDCW) | 47.35 | 3,25,509 | 0.64 |
| Aditya Birla SL Equity Hybrid '95 Fund (G) | 47.35 | 3,25,509 | 0.64 |
| Canara Robeco Equity Hybrid Fund (IDCW-M) | 37.82 | 2,60,000 | 0.45 |
| Canara Robeco Equity Hybrid Fund - Direct (G) | 37.82 | 2,60,000 | 0.45 |
| Canara Robeco Equity Hybrid Fund - Direct (IDCW-M) | 37.82 | 2,60,000 | 0.45 |
| Canara Robeco Equity Hybrid Fund (G) | 37.82 | 2,60,000 | 0.45 |
| ICICI Pru Regular Savings Fund - Direct (G) | 12.34 | 84,837 | 0.37 |
| ICICI Pru Regular Savings Fund - Direct (IDCW-Q) | 12.34 | 84,837 | 0.37 |
Load more
Research Reports
| Date | Broker | Action | Prices(₹) | Report |
|---|---|---|---|---|
| Data Not Found | ||||
Stock Strength
| Today's Low/High (₹) | 1,222.50 1,250.00 |
| Week Low/High (₹) | 1,215.60 1,376.00 |
| Month Low/High (₹) | 1,215.60 1,597.00 |
| Year Low/High (₹) | 1,222.50 2,221.00 |
| All time Low/High (₹) | 861.50 4,350.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -8.26% | -8.16% | -1.88% | -2.57% |
| 1 Month | -21.05% | -20.94% | -5.02% | -5.93% |
| 3 Month | -32.51% | -32.49% | -4.31% | -4.99% |
| 6 Month | -45.02% | -45.03% | -0.23% | -1.36% |
| 1 Year | -65.17% | -65.20% | -0.98% | -2.33% |
| 3 Year | - | - | 46.00% | 46.50% |
Company Info
Company Information
Director : QIYU CHEN
Company Sec. & Compli. Officer : SAMPATH KUMAR PALLERLAMUDI
Registered Office: Sy No 143-148 150&151 Nr Gandi, X Roads D P Pally Dundigal,Hyderabad,Telangana-500043 Ph: 91-40-30510999
FAQs about Gland Pharma Ltd
1. What's the Gland Pharma Ltd share price today?
Gland Pharma Ltd share price was Rs 1,245.00 at close on 22nd Mar 2023. Gland Pharma Ltd share price was up by 1.08% over the previous closing price of Rs 1,231.75. Gland Pharma Ltd share price trend:
- Last 1 Month: Gland Pharma Ltd share price moved down by 21.05% on BSE
- Last 3 Months: Gland Pharma Ltd share price moved down by 32.51% on BSE
- Last 12 Months: Gland Pharma Ltd share price moved down by 65.17% on BSE
- Last 3 Years: Gland Pharma Ltd price moved up by % on BSE
2. How can I quickly analyse the performance of the Gland Pharma Ltd stock?
The performance of the Gland Pharma Ltd stock can be quickly analysed on the following metrics:
- The stock's PE is 29.12
- Price to book value ratio is 2.33
- Dividend yield of 1.33
- The EPS (trailing 12 months) of the Gland Pharma Ltd stock is Rs 42.76
3. What is the market cap of Gland Pharma Ltd?
Gland Pharma Ltd has a market capitalisation of Rs 20,505 crore.
4. What is Gland Pharma Ltd's 52-week high/low share price?
The Gland Pharma Ltd’s 52-week high share price is Rs 2,220.95 and 52-week low share price is Rs 1,222.50.
5. Is the Gland Pharma Ltd profitable?
On a consolidated basis, Gland Pharma Ltd reported a profit of Rs 295.12 crore on a total income of Rs 1,075.84 crore for the quarter ended 2024. For the year ended Dec 2022, Gland Pharma Ltd had posted a profit of Rs 231.95 crore on a total income of Rs 999.80 crore.
6. Which are Gland Pharma Ltd’s peers in the Health care sector?
Gland Pharma Ltd’s top 5 peers in the Health care sector are Biocon, Syngene Intl., Glaxosmi. Pharma, Gland Pharma, Ipca Labs., Laurus Labs, Pfizer.
7. Who owns how much in Gland Pharma Ltd?
Key changes to the Gland Pharma Ltd shareholding are as follows:
- Promoter holding in Gland Pharma Ltd has gone down to 57.86 per cent as of Dec 2022 from 58.00 per cent as of Mar 2022.
